These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 642934)

  • 1. Inhibition of drug metabolism by a prodrug: 9-beta-D-arabinofuranosyladenine 5'-valerate as an inhibitor of adenosine deaminase.
    Lipper RA; Machkovech SM; Drach JC; Higuchi WI
    Mol Pharmacol; 1978 Mar; 14(2):366-9. PubMed ID: 642934
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.
    Lee SH; Caron N; Kimball AP
    Cancer Res; 1977 Jul; 37(7 Pt 1):1953-5. PubMed ID: 861931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the effects of infusion of enzyme inhibitors on mouse adenosine deaminase.
    Trotta PP; Ahland MP; Brown GF; Balis ME
    Mol Pharmacol; 1978 Jan; 14(1):199-209. PubMed ID: 625284
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of adenosine deaminase by deaza derivatives of adenosine and purine riboside.
    Lupidi G; Riva F; Cristalli G; Grifantini M
    Ital J Biochem; 1982; 31(6):396-403. PubMed ID: 7184903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical basis of the increased activity of 9-beta-D-arabinofuranosyladenine in the presence of inhibitors of adenosine deaminase.
    Plunkett W; Alexander L; Chubb S; Loo TL
    Cancer Res; 1979 Sep; 39(9):3655-60. PubMed ID: 476690
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.
    Suling WJ; Rice LS; Shannon WM
    Cancer Treat Rep; 1978 Mar; 62(3):369-73. PubMed ID: 647695
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
    Cass CE; Tan TH; Selner M
    Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an adenosine deaminase inhibitor on the uptake and metabolism of arabinosyl adenine (Vidarabine) by intact human erythrocytes.
    Chang T; Glazko AJ
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):127-40. PubMed ID: 935646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two approaches that increase the activity of analogs of adenine nucleosides in animal cells.
    Plunkett W; Cohen SS
    Cancer Res; 1975 Jun; 35(6):1547-54. PubMed ID: 1079475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased toxicity of 9-beta-D-arabinofuranosyladenine in the presence of an inhibitor of adenosine deaminase.
    Plunkett W; Cohen SS
    Ann N Y Acad Sci; 1977 Mar; 284():91-102. PubMed ID: 280161
    [No Abstract]   [Full Text] [Related]  

  • 11. Trazodone, a nontricyclic antidepressant, is an inhibitor of adenosine deaminase.
    Sheid B
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):149-52. PubMed ID: 3983468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of bovine heart adenosine deaminase activity by some pyrimidine analogues.
    Pechán I; Pechánová E; Krizko J; Starková B; Cihák A
    Neoplasma; 1983; 30(1):109-11. PubMed ID: 6835435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
    Plunkett W; Chubb S; Alexander L; Montgomery JA
    Cancer Res; 1980 Jul; 40(7):2349-55. PubMed ID: 6966966
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzymatic synthesis of purine 2'-deoxyriboside and its properties as an inhibitor of adenosine deaminases from calf intestinal mucosa and Bacillus cereus.
    Caffaz S; Allegrini S; Cercignani G
    Ital J Biochem; 1990; 39(2):115-20. PubMed ID: 2113897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
    Borondy PE; Chang T; Maschewske E; Glazko AJ
    Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160
    [No Abstract]   [Full Text] [Related]  

  • 17. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
    Helland S; Ueland PM
    Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of substituted 1,2,3-triazoles on adenosine deaminase, guanine deaminase and xanthine oxidase.
    Lucacchini A; Segnini D; Da Settimo A; Livi O
    Ital J Biochem; 1979; 28(3):194-206. PubMed ID: 583599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine deaminase inhibition for immunosuppression.
    Chassin MM; Chirigos MA; Johns DG; Adamson RH
    N Engl J Med; 1977 May; 296(21):1232. PubMed ID: 854065
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution and inhibition of adenosine deaminase in tissues of man, rat, and mouse.
    Ho DH; Pincus C; Carter CJ; Benjamin RS; Freireich EJ; Bodey GP
    Cancer Treat Rep; 1980; 64(4-5):629-33. PubMed ID: 6968622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.